Novartis to invest $500 million in new Singapore site

ZURICH (Reuters) - Swiss drugmaker Novartis said on Wednesday it would spend more than $500 million on a new biotechnology production site in Singapore to support its growing pipeline of biologics.

via Reuters: Health News Read More Here..